---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-093268"
form_type: "8-K"
ticker: "JBIO"
cik: "0001798749"
company_name: "Jade Biosciences, Inc."
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:34:09.251612+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Aerovate Therapeutics appoints Allison Dorval to Board of Directors

## Summary
- Allison Dorval, CFO of Voyager Therapeutics, appointed to Board effective July 15, 2021.
- Dorval appointed chair of Audit Committee; Joshua Resnick resigns from Audit Committee.
- Maha Katabi steps down as Audit Committee chair but remains a member; Dorval qualifies as independent and financial expert.
- Dorval to serve as Class II director until the 2023 annual meeting of stockholders.

## SEC filing metadata
- accession: 0001104659-21-093268
- form_type: 8-K
- ticker: JBIO
- cik: 0001798749
- company_name: Jade Biosciences, Inc.
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/0001104659-21-093268-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/tm2122221d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-093268
- JSON: https://secwatch.observer/filing/0001104659-21-093268.json
- Plain text: https://secwatch.observer/filing/0001104659-21-093268.txt

## Key facts
- Executive change
  Allison Dorval was appointed as Director at Jade Biosciences, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Allison Dorval as a member of the Board, effective as of July 15, 2021
  evidence_url: https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/0001104659-21-093268-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.